Egetis Therapeutics AB (publ) (STO:EGTX)

Egetis Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	202.6	351	303.3	127.7	144	287.85
Cash & Short-Term Investments	202.6	351	303.3	127.7	144	287.85
Cash Growth	5.19%	15.73%	137.51%	-11.32%	-49.97%	12.84%
Accounts Receivable	29.1	15.5	28.2	3.8	3.5	3.88
Other Receivables	8.7	8.1	8.4	6.7	3.3	3.58
Receivables	37.8	23.6	36.6	10.5	6.8	7.46
Inventory	1.4	1	0.7	0.6	0.7	3.14
Prepaid Expenses	4.5	4.1	4.4	8.2	1.3	1.42
Other Current Assets	0.1	0.4	0.9	0.4	0.1	0
Total Current Assets	246.4	380.1	345.9	147.4	152.9	299.87
Property, Plant & Equipment	11.1	2.6	4.4	2.7	4.3	4.74
Long-Term Investments	0.8	0.8	0.8	0.8	0.8	-
Other Intangible Assets	2.7	3.2	4.3	5.4	6.5	7.57
Long-Term Deferred Tax Assets	2	0.6	-	-	-	-
Long-Term Deferred Charges	391.3	404.8	404.8	404.8	404.8	404.82
Other Long-Term Assets	0.1	0.2	-	-	-	-
Total Assets	654.4	792.3	760.2	561.1	569.3	717
Accounts Payable	15.7	25.7	28.7	20	4.6	15.61
Accrued Expenses	168.5	131	47.2	12.7	5.3	3.51
Current Portion of Long-Term Debt	30.9	30.1	5.2	-	-	-
Current Portion of Leases	-	2.5	2.2	1.6	1.5	1.14
Current Income Taxes Payable	-	0.2	0.1	-	-	-
Other Current Liabilities	11.6	14.7	20.5	15.1	27.8	49.88
Total Current Liabilities	226.7	204.2	103.9	49.4	39.2	70.14
Long-Term Debt	58.8	84.1	103.4	-	-	-
Long-Term Leases	7.1	0.4	2.2	1.1	2.7	3.53
Long-Term Deferred Tax Liabilities	2	0.5	-	-	-	-
Other Long-Term Liabilities	4.7	10.2	5.1	4.4	0.4	12.61
Total Liabilities	299.3	299.4	214.6	54.9	42.3	86.28
Common Stock	20.4	20.4	15.4	11.3	8.7	8.69
Additional Paid-In Capital	2,058	2,058	1,780	1,428	1,263	1,263
Retained Earnings	-1,752	-1,610	-1,267	-939.6	-745.8	-641.25
Comprehensive Income & Other	28.5	24.9	16.7	6.1	1.3	0.45
Shareholders' Equity	355.1	492.9	545.6	506.2	527	630.72
Total Liabilities & Equity	654.4	792.3	760.2	561.1	569.3	717
Total Debt	96.8	117.1	113	2.7	4.2	4.67
Net Cash (Debt)	105.8	233.9	190.3	125	139.8	283.18
Net Cash Growth	28.87%	22.91%	52.24%	-10.59%	-50.63%	11.06%
Net Cash Per Share	0.29	0.75	0.73	0.64	0.78	4.20
Filing Date Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Total Common Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Working Capital	19.7	175.9	242	98	113.7	229.73
Book Value Per Share	0.99	1.37	1.86	2.36	3.19	3.82
Tangible Book Value	352.4	489.7	541.3	500.8	520.5	623.15
Tangible Book Value Per Share	0.98	1.36	1.85	2.33	3.15	3.78
Machinery	-	0.1	0.3	0.2	0.3	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.